Conference Description
The Drug Resistance GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
Drug resistance is a threat shared across multiple fields in medicine and agriculture. It is a primary area of ongoing basic, translational, and biotechnological research that often exists within siloed areas of research. The Drug Resistance Gordon Research Conference aims explore concepts and principles that transcend individual fields in drug resistance by assembling a multidisciplinary community of academic researchers, industry scientists, physicians, educators, and other stakeholders studying different aspects of drug resistance. The 2024 meeting will bring together investigators who study drug resistance in cancer, infectious disease, agriculture, and newer areas to the drug resistance space, such as neuroscience. We are particularly interested in welcoming researchers who utilize genomics, systems biology, chemical biology and different faucets of quantitative research to inform our collective thinking on resistance. By learning about a diverse tools and approaches used by different communities we aim to uncover new strategies that overcome the challenges of drug resistance in individual organisms and across populations broadly.
The conference will recruit participants with diverse backgrounds, providing opportunities for students and young investigators to present their research through poster and oral presentations. This meeting has been historically characterized by strong interaction between investigators that do not interact in traditional forums; we plan to continue this tradition and invite researchers who don’t necessarily consider themselves part of the “drug resistance” community to join us: we welcome new voices and ideas!
The topics, speakers, and discussion leaders for the conference sessions are displayed below. The conference chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by February 24, 2024. Please check back for updates.
Keynote Session: Evolved Drug Resistance
Discussion Leaders
-
Priscilla Yang (Stanford University School of Medicine, United States)
Speakers
-
Roy Kishony (Technion- Israel Institute of Technology, Israel)
Bet-Hedging Strategies in Drug Tolerance and Resistance
Discussion Leaders
-
Arjun Raj (University of Pennsylvania, United States)
Speakers
-
Yaara Oren (Tel Aviv University, Israel)
-
Bree Aldridge (Tufts University, United States)
Artificial Intellegence in Drug Resistance
Discussion Leaders
-
Yogesh Goyal (Northwestern University, United States)
Speakers
-
Shuyi Ma (Seattle Children's Research Institute, United States)
-
Jason Yang (Rutgers New Jersey Medical School, United States)
Microbiome and Drug Resistance
Discussion Leaders
-
Shuyi Ma (Seattle Children's Research Institute, United States)
Speakers
-
Susan Bullman (Fred Hutchinson Cancer Center, United States)
-
Sean Gibbons (Institute for Systems Biology, United States)
-
Lisa Maier (University of Tübingen, Germany)
Multi-Drug Resistance
Discussion Leaders
-
Susan Rosenberg (Baylor College of Medicine, United States)
Speakers
-
Sydney Shaffer (University of Pennsylvania, United States)
-
Jean-Luc Bodmer (The Bill and Melinda Gates Foundation, United States)
Surveillance and Detection of Drug Resistance
Discussion Leaders
-
Olusegun Soge (University of Washington, United States)
Speakers
-
Chiahao Tsui (Biobot Analytics, United States)
-
Nawaporn Onkokesung (Bayer AG, Germany)
-
David Sherman (University of Washington, United States)
Tackling Resistance in Neuroscience
Discussion Leaders
-
Aaron Goldman (Harvard Medical School, United States)
Speakers
-
Stephen Moss (Tufts University, United States)
-
Jamie Maguire (Tufts University School of Medicine, United States)
New Strategies to Overcome Resistance
Discussion Leaders
-
Erin Duffy (CARB-X, United States)
Speakers
-
Karla Kirkegaard (Stanford University School of Medicine, United States)
-
Peijun Ma (St Jude Children's Research Hospital, United States)
-
Mithila Jugulam (Kansas State University, United States)
Keynote Session: Overcoming Drug Resistance
Discussion Leaders
-
Zemer Gitai (Princeton University, United States)
Speakers
-
Leor Weinberger (University of California, San Francisco )
-
Celia Schiffer (University of Massachusetts Medical School, United States)
The GRC Power Hour™
Organizers
-
Emily Bordeleau (University of British Columbia, Canada)